Biotechnology Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference – Compass Therapeutics (NASDAQ:CMPX) Read more
Biotechnology Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference – Compass Therapeutics (NASDAQ:CMPX) Read more
Biotechnology Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical Trial – Compass Therapeutics (NASDAQ:CMPX) Read more
